Press Releases
Mylan NV Launches First Generic Doryx Delayed-Release Tablets, 200 mg
Mylan N.V. announced the U.S. launch of Doxycycline Hyclate Delayed-Release (DR) Tablets USP, 200 mg, a generic version of Mayne's Doryx®. Mylan received final...
News
STELARA Induced Clinical Response And Remission In Phase 3 Study For The Treatment Of Patients With Moderate To Severe Crohn’s Disease
Janssen Research & Development, LLC (Janssen) Phase 3 data presented for the first time at Digestive Disease Week® 2016 showed that a significantly greater...
Press Releases
Boehringer Ingelheim and BioMed X start new project to explore and develop unprecedented new treatment approaches for psychiatric diseases applying crowdsourcing
Aims to identify maladaptive brain circuits to find new approaches for treating psychiatric diseases Second Boehringer Ingelheim crowdsourcing project with BioMed X...
Press Releases
CHAMPIX European Union Label Updated To Include New Safety And Efficacy Data From The EAGLES Clinical Trial Following Endorsement From CHMP
Pfizer Inc announced that the European Summary of Product Characteristics (SmPC) and Package Leaflet for CHAMPIX® (varenicline) have been updated to include safety and...
Press Releases
Allergan Launches IBS-D on Tract, New Online Resource to Support Patients with Irritable Bowel Syndrome with Diarrhea
IBSDonTract.com provides clear information, symptom management strategies and interactive tools for people with IBS-D, which affects up to 15 million adults in the U.S.Allergan...
News
Novartis Entresto given strong Class I recommendation in both US and EU heart failure guidelines, less than a year after regulatory approvals
US guidelines now recommend Entresto as standard of care for HFrEF as an alternative to ACEs or ARBs; call for doctors to switch...
Press Releases
Pfizer Inc Announces EMA acceptance for Trumenba (Meningococcal Group B Vaccine) marketing authorization application review
Pfizer Inc announced the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for TRUMENBA® (Meningococcal Group B Vaccine) for review. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read